These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 10987675)

  • 21. Dual hormonal replacement therapy with insulin and recombinant human insulin-like growth factor (IGF)-I in insulin-dependent diabetes mellitus: effects on the growth hormone/IGF/IGF-binding protein system.
    Thrailkill K; Quattrin T; Baker L; Litton J; Dwigun K; Rearson M; Poppenheimer M; Kotlovker D; Giltinan D; Gesundheit N; Martha P
    J Clin Endocrinol Metab; 1997 Apr; 82(4):1181-7. PubMed ID: 9100593
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dose-dependent effects of recombinant human insulin-like growth factor (IGF)-I/IGF binding protein-3 complex on overnight growth hormone secretion and insulin sensitivity in type 1 diabetes.
    Saukkonen T; Amin R; Williams RM; Fox C; Yuen KC; White MA; Umpleby AM; Acerini CL; Dunger DB
    J Clin Endocrinol Metab; 2004 Sep; 89(9):4634-41. PubMed ID: 15356074
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chronic administration of growth hormone (GH) to adult chickens exerts marked effects on circulating concentrations of insulin-like growth factor-I (IGF-I), IGF binding proteins, hepatic GH regulated gene I, and hepatic GH receptor mRNA.
    Radecki SV; McCann-Levorse L; Agarwal SK; Burnside J; Proudman JA; Scanes CG
    Endocrine; 1997 Apr; 6(2):117-24. PubMed ID: 9225125
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of low-dose recombinant human insulin-like growth factor-I on insulin sensitivity, growth hormone and glucagon levels in young adults with insulin-dependent diabetes mellitus.
    Acerini CL; Harris DA; Matyka KA; Watts AP; Umpleby AM; Russell-Jones DL; Dunger DB
    Metabolism; 1998 Dec; 47(12):1481-9. PubMed ID: 9867078
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Insulin-like growth factors (IGFs) and IGF-I treatment in the adolescent with insulin-dependent diabetes mellitus.
    Dunger DB; Cheetham TD; Crowne EC
    Metabolism; 1995 Oct; 44(10 Suppl 4):119-23. PubMed ID: 7476304
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Is growth hormone hypersecretion in diabetic adolescent girls also a daytime problem?
    Halldin MU; Tylleskär K; Hagenäs L; Tuvemo T; Gustafsson J
    Clin Endocrinol (Oxf); 1998 Jun; 48(6):785-94. PubMed ID: 9713569
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stimulation of glucose uptake by insulin-like growth factor II in human muscle is not mediated by the insulin-like growth factor II/mannose 6-phosphate receptor.
    Burguera B; Elton CW; Caro JF; Tapscott EB; Pories WJ; Dimarchi R; Sakano K; Dohm GL
    Biochem J; 1994 Jun; 300 ( Pt 3)(Pt 3):781-5. PubMed ID: 8010960
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effects of pubertal status and glycemic control on the growth hormone-IGF-I axis in boys with insulin-dependent diabetes mellitus.
    Clark PA; Clarke WL; Pedadda S; Reiss A; Langlois C; Nieves-Rivera F; Rogol AD
    J Pediatr Endocrinol Metab; 1998; 11(3):427-35. PubMed ID: 11517959
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Insulin-like growth factor-I treatment of growth disorders, diabetes mellitus and insulin resistance.
    Ranke MB
    Trends Endocrinol Metab; 2005; 16(4):190-7. PubMed ID: 15860416
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recombinant human insulin-like growth factor-I (rhIGF-I) therapy in adults with type 1 diabetes mellitus: effects on IGFs, IGF-binding proteins, glucose levels and insulin treatment.
    Carroll PV; Umpleby M; Alexander EL; Egel VA; Callison KV; Sönksen PH; Russell-Jones DL
    Clin Endocrinol (Oxf); 1998 Dec; 49(6):739-46. PubMed ID: 10209561
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Growth hormone insulin-like growth factor I axis in insulin-dependent diabetes mellitus.
    Dunger DB; Cheetham TD
    Horm Res; 1996 Jul; 46(1):2-6. PubMed ID: 8854134
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Insulin-like growth factor-I in man enhances lipid mobilization and oxidation induced by a growth hormone pulse.
    Bianda TL; Hussain MA; Keller A; Glatz Y; Schmitz O; Christiansen JS; Alberti KG; Froesch ER
    Diabetologia; 1996 Aug; 39(8):961-9. PubMed ID: 8858219
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of the selective estrogen receptor modulator, raloxifene, on the somatotropic axis and insulin-glucose homeostasis.
    Oleksik AM; Duong T; Pliester N; Asma G; Popp-Snijders C; Lips P
    J Clin Endocrinol Metab; 2001 Jun; 86(6):2763-8. PubMed ID: 11397884
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mecasermin (recombinant human insulin-like growth factor I).
    Rosenbloom AL
    Adv Ther; 2009 Jan; 26(1):40-54. PubMed ID: 19198769
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Growth promotion by insulin-like growth factor I in hypophysectomized and diabetic rats.
    Zapf J
    Mol Cell Endocrinol; 1998 May; 140(1-2):143-9. PubMed ID: 9722182
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Insulin-like growth factor binding protein production in bovine retinal endothelial cells.
    Giannini S; Cresci B; Manuelli C; Fujita-Yamaguchi Y; Romagnani P; Mohan S; Rotella CM
    Metabolism; 1997 Dec; 46(12):1367-79. PubMed ID: 9439529
    [TBL] [Abstract][Full Text] [Related]  

  • 37. C-reactive protein and the insulin-like growth factor (IGF)-system in relation to risk of cardiovascular disease in different ethnic groups.
    Heald AH; Anderson SG; Ivison F; Laing I; Gibson JM; Cruickshank K
    Atherosclerosis; 2003 Sep; 170(1):79-86. PubMed ID: 12957685
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A paradoxical gender dissociation within the growth hormone/insulin-like growth factor I axis during protracted critical illness.
    Van den Berghe G; Baxter RC; Weekers F; Wouters P; Bowers CY; Veldhuis JD
    J Clin Endocrinol Metab; 2000 Jan; 85(1):183-92. PubMed ID: 10634385
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of increased growth hormone secretion on carbohydrate metabolism in adolescents with diabetes.
    Dunger DB; Edge JA; Pal R; Taylor AM; Holly JM; Matthews DR
    Acta Paediatr Scand Suppl; 1991; 377():69-77; discussion 78. PubMed ID: 1723835
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Function of the growth hormone-insulin-like growth factor I axis in the profoundly growth-retarded diabetic child: evidence for defective target organ responsiveness in the Mauriac syndrome.
    Mauras N; Merimee T; Rogol AD
    Metabolism; 1991 Oct; 40(10):1106-11. PubMed ID: 1719338
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.